患有ADHD的儿童多营养补充剂后的kynurenine代谢物不变:MADDY研究中的二次数据分析
Alisha M Bruton1, Hayleigh K Ast2, Lydia Norby-Adams2,3
1Center for Mental Health Innovation, Department of Psychiatry, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR, USA. BrutonA@ohsu.edu.
No abstract available in PubMed .
更多相关视频
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
相关概念视频
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drugs Affecting Neurotransmitter Synthesis
Pharmacokinetics in Pediatric Patients: Drug Excretion
Biosynthesis of Nucleic Acids
Drugs Affecting Neurotransmitter Release or Uptake
